Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
312
312 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- JMBI-001Phase 21 trial
Chengdu Anticancer Bioscience, Ltd. · Advance Solid Tumors, Lymphoma, Non-Hodgkin
- JNJ-90014496Phase 21 trial
Johnson & Johnson (Janssen) · Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse
- KITE-363Phase 21 trial
Gilead Sciences · Relapsed and/or Refractory B-cell Lymphoma
- lacutamabIPH4102Phase 21 trial
Innate Pharma · Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome
- LB-100Phase 21 trial
Lixte Biotechnology Holdings, Inc. · Myelodysplastic Syndromes
- LBL-034Phase 21 trial
Nanjing Leads Biolabs Co.,Ltd · Relapsed/Refractory Multiple Myeloma
- Liso-celPhase 21 trial
Bristol Myers Squibb · Lymphoma
- LNP1265Phase 21 trial
Regeneron · Hemophilia B
- MAX-40279Phase 21 trial
Maxinovel Pty., Ltd. · Acute Myeloid Leukemia
- MBS303Phase 21 trial
Beijing Mabworks Biotech Co., Ltd. · Non-Hodgkin's Lymphoma
- MDSY-1240Phase 21 trial
Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic
- MDX2003Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Lymphoma, Waldenström Macroglobulinemia (WM), DLBCL - Diffuse Large B Cell Lymphoma
- ME-401Phase 21 trial
Kyowa Kirin Co., Ltd. · Indolent B-cell Non-Hodgkin's Lymphoma
- MEN1703SEL24, Dapolsertib hydrochloridePhase 21 trial
Ryvu Therapeutics SA · Non-Hodgkin Lymphoma, B-cell
- MS-553Phase 21 trial
MingSight Pharmaceuticals, Inc · CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma)
- NVG-2089Phase 21 trial
Nuvig Therapeutics, Inc. · Immune Thrombocytopenia (ITP)
- OriCAR-017Phase 21 trial
OriCell Therapeutics Co., Ltd. · Relapsed and/or Refractory Multiple Myeloma
- OSE-279Phase 21 trial
OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
- PBSS1113Phase 21 trial
Chaser Therapeutics, Inc. · Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)
- PegenzileukinSAR444245Phase 21 trial
Sanofi · Plasma Cell Myeloma Refractory
- PN20Phase 21 trial
Chongqing Peg-Bio Biopharm Co., Ltd. · Thrombocytopenia Associated With Chronic Liver Disease
- REC-1245Phase 21 trial
Recursion Pharmaceuticals Inc. · Unresectable, Locally Advanced, Metastatic Cancers
- REGN17372Phase 21 trial
Regeneron · Relapsed Refractory Multiple Myeloma (RRMM)
- REGN7945Phase 21 trial
Regeneron · Relapsed/Refractory Multiple Myeloma
- REGN7999Phase 21 trial
Regeneron · Non-Transfusion Dependent Beta-Thalassemia (NTDT)
- REGN9220Phase 21 trial
Regeneron · Diffuse Large B-Cell Lymphoma (DLBCL)
- REGV131Phase 21 trial
Regeneron · Hemophilia B
- Relmacabtagene AutoleucelJWCAR029Phase 21 trial
Shanghai Ming Ju Biotechnology Co., Ltd. · Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma
- S241656Phase 21 trial
Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia
- S243249Phase 21 trial
Servier · Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Myeloid Leukemia
- sabatolimabMBG453Phase 21 trial
Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
- SAL-0951SAL-0951 groupPhase 21 trial
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Anemia
- SAR439459Phase 21 trial
Sanofi · Plasma Cell Myeloma Refractory
- SG2918Phase 21 trial
Hangzhou Sumgen Biotech Co., Ltd. · Relapsed/Refractory Multiple Myeloma
- SKLB1028Phase 21 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Newly Diagnosed Acute Myeloid Leukemia (AML)
- SLN124Phase 21 trial
Silence Therapeutics plc · Polycythemia Vera
- SNH-119014Phase 21 trial
ScinnoHub Pharmaceutical Co., Ltd. · Thalassemia
- SP-420Phase 21 trial
Pharmacosmos A/S · Beta Thalassemia Major Anemia, Myelodysplastic Syndrome
- spartalizumabPDR001Phase 21 trial
Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
- SPK-8011QQRO7878488Phase 21 trial
Roche (Genentech) · Hemophilia A
- SSS06Phase 21 trial
Shenyang Sunshine Pharmaceutical Co., LTD. · Chemotherapy-induced Anemia, Non-myeloid Malignancies
- STI-6129Phase 21 trial
Zhejiang ACEA Pharmaceutical Co. Ltd. · Relapsed or Refractory Multiple Myeloma
- STSA-1301Phase 21 trial
Jiangsu BioJeTay Biotechnology Co., Ltd. · Primary Immune Thrombocytopenia (ITP)
- TAK-007Phase 21 trial
Takeda · Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- TBI-1501Phase 21 trial
Takara Bio Inc. · Lymphoblastic Leukemia, Acute Adult
- TBS-2025trovostobartPhase 21 trial
TuHURA Biosciences, Inc. · Acute Myeloid Leukemia
- TC011Phase 21 trial
TICAROS Co., Ltd. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)
- TGD001Phase 21 trial
TargED Biopharmaceuticals B.V. · Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia
- TGRX-814Phase 21 trial
Shenzhen TargetRx Co., Ltd. · Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia
- TL-895Phase 21 trial
Telios Pharma, Inc. · Myelofibrosis, Primary Myelofibrosis, Post-PV MF
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.